| Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. V Zolota, A Gerokosta, M Melachrinou, A Kominea, C Aletra, CD Scopa Anticancer research 19 (4B), 3269-3274, 1999 | 644* | 1999 |
| High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology VK Anagnostou, FJ Lowery, V Zolota, V Tzelepi, A Gopinath, C Liceaga, ... BMC cancer 10, 1-11, 2010 | 91 | 2010 |
| The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and … AC Tsamandas, D Kardamakis, P Tsiamalos, A Liava, V Tzelepi, ... Anticancer research 29 (2), 703-709, 2009 | 88 | 2009 |
| Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values G Cserni, A Vörös, I Liepniece-Karele, S Bianchi, V Vezzosi, D Grabau, ... The Breast 23 (3), 259-263, 2014 | 83 | 2014 |
| ILK expression in colorectal cancer is associated with EMT, cancer stem cell markers and chemoresistance D Tsoumas, S Nikou, E Giannopoulou, SC Tsaniras, C Sirinian, I Maroulis, ... Cancer genomics & proteomics 15 (2), 127-141, 2018 | 75 | 2018 |
| Mammary tuberculosis mimicking breast cancer: a case report I Maroulis, C Spyropoulos, V Zolota, E Tzorakoleftherakis Journal of medical case reports 2, 1-4, 2008 | 75 | 2008 |
| Prognostic value of stromal tumor-infiltrating lymphocytes in young, node-negative, triple-negative breast cancer patients who did not receive (neo) adjuvant systemic therapy VMT de Jong, Y Wang, ND Ter Hoeve, M Opdam, N Stathonikos, ... Journal of Clinical Oncology 40 (21), 2361, 2022 | 72 | 2022 |
| Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents AA Argyriou, V Zolota, O Kyriakopoulou, HP Kalofonos J BUON 15 (3), 435-446, 2010 | 70 | 2010 |
| Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study AC Tsamandas, K Thomopoulos, V Zolota, T Kourelis, T Karatzas, ... Modern pathology 16 (12), 1273-1288, 2003 | 64 | 2003 |
| Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome V Zolota, AC Tsamandas, P Aroukatos, V Panagiotopoulos, T Maraziotis, ... Neuropathology 28 (1), 35-42, 2008 | 59 | 2008 |
| The role of obesity in the immune response during sepsis AS Kolyva, V Zolota, D Mpatsoulis, G Skroubis, EE Solomou, IG Habeos, ... Nutrition & diabetes 4 (9), e137-e137, 2014 | 50 | 2014 |
| Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study M O’Loughlin, X Andreu, S Bianchi, E Chemielik, A Cordoba, G Cserni, ... Breast cancer research and treatment 171, 1-9, 2018 | 48 | 2018 |
| Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient … Z Kefalopoulou, V Tzelepi, V Zolota, PD Grivas, C Christopoulos, ... Journal of neuro-oncology 106, 23-31, 2012 | 47 | 2012 |
| The Potential Role of TGF [beta] 1, TGF [beta] 2 and TGF [beta] 3 Protein Expression in Colorectal Carcinomas AC Tsamandas, MD Dimitrios Kardamakis, P Ravazoula, V Zolota, ... Strahlentherapie und Onkologie 180 (4), 201, 2004 | 46 | 2004 |
| Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients … V Zolota, C Sirinian, M Melachrinou, A Symeonidis, DS Bonikos Pathology-Research and Practice 203 (4), 199-207, 2007 | 45 | 2007 |
| Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study AC Tsamandas, I Syrokosta, K Thomopoulos, V Zolota, D Dimitropoulou, ... Liver International 26 (7), 817-826, 2006 | 43 | 2006 |
| Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study CD Scopa, AC Tsamandas, V Zolota, HP Kalofonos, A Batistatou, ... Digestive diseases and sciences 48, 1990-1997, 2003 | 43 | 2003 |
| Modulation of the Na+–H+ antiport activity by adrenaline on erythrocytes from normal and obese individuals D Bourikas, M Kaloyianni, M Bougoulia, Z Zolota, G Koliakos Molecular and cellular endocrinology 205 (1-2), 141-150, 2003 | 40 | 2003 |
| Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature CA Gogos, V Nikolopoulou, V Zolota, V Siampi, A Vagenakis Journal of hepatology 30 (2), 321-324, 1999 | 40 | 1999 |
| Analitičeskaja chimija zolota AI Busev, VM Ivanov Nauka, 1973 | 40 | 1973 |
V TZELEPIAssistant Professor, University of PatrasVerified email at g.upatras.gr
